## Activist Fund AVI Demands Rohto Pharmaceutical Chairman Resign Over Governance Concerns
Asset Value Investors Ltd. has escalated pressure on Rohto Pharmaceutical Co., publicly calling for the Japanese drugmaker's chairman to leave the board of directors. The move marks a significant confrontation between a prominent activist shareholder and one of Japan's best-known consumer healthcare companies, signaling that governance challenges in Japan's pharmaceutical sector face mounting scrutiny from international investors.

AVI, a London-based investment firm, has built a substantial position in Rohto and is now pushing for leadership changes it argues are necessary to improve the company's governance standards and strategic direction. The activist investor's campaign centers on concerns about board composition and oversight effectiveness at the Osaka-based company, which manufactures popular over-the-counter medications and eye care products. This marks at least the second high-profile governance dispute AVI has initiated involving a Japanese listed company, demonstrating a sustained push by the fund to reshape corporate behavior at targets it views as underperforming on shareholder accountability.

The development raises pressure on other Japanese pharmaceutical and consumer healthcare companies to examine their own governance structures, as international activist funds increasingly view the sector as ripe for intervention. Rohto now faces the challenge of responding to specific allegations while managing potential reputational fallout among domestic and foreign investors. The outcome of this dispute could set precedents for how Japanese companies handle activist demands and whether boardrooms will be more responsive to shareholder concerns in a market historically known for passive investor relations.
---
- **Source**: Bloomberg Markets
- **Sector**: The Vault
- **Tags**: activist_investing, corporate_governance, Japanese_pharmaceuticals, shareholder_activism, AVI
- **Credibility**: unverified
- **Published**: 2026-04-30 11:24:07
- **ID**: 78572
- **URL**: https://whisperx.ai/en/intel/78572